liver cancer
Conditions
Interventions
Control Group:The drug treatment plan was made by reference to the results of high-throughput drug sensitivity test.
Control Group:Use An empirical drug protocol based on the guidelines
Sponsors
First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-70 years; 2. Preoperative clinical data, examination information, imaging information for the primary liver cancer patients; 3. A patient who has a complete or partial resection of a liver tumor; 4. First-time detection of liver cancer or recurrence of liver cancer; 5. Postoperative examination revealed one of the following: (1) Hepatocellular Carcinoma; (2) Cholangiocarcinoma; (3) Mixed Cell Carcinoma of liver.
Exclusion criteria
Exclusion criteria: 1. Combined with other malignant tumors; 2. Due to the small size of liver cancer tissue, it is impossible to obtain enough samples for primary tumor cell culture; 3. The primary Hepatoma cells could not be obtained because of the contamination of the specimens caused by various factors such as sampling, transportation and culture; 4. Accompanied by cardiovascular and cerebrovascular, kidney, endocrine system, hematopoiesis and other serious diseases; 5. Pregnant and lactating women and those who have recently prepared for pregnancy; 6. Patients with severe hypertension, systemic circulatory failure and DIC that are difficult to correct with medication; 7. Unable or unwilling to cooperate because of neurological or mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival;Disease-free survival;progression-free-survival;Time to progression;Time to treatment failure;Local control rate in June and December;Tumor Marker; | — |
Countries
China
Contacts
Public ContactShi Zhengrong
First Affiliated Hospital of Chongqing Medical University
Outcome results
None listed